Response to Covid-19 in Africa

Home / Healthcare and public health research / Response to Covid-19 in Africa

April 20, 2020 Dario Scaramuzzi 0 Comments 6 tags

The impact of Covid-19 in Africa is a ticking bomb on which the European Union (EDCTP) intervenes by supporting research projects. In response to this, a consortium of African and European universities and research institutes developed the ITAIL-COVID-19 project, aimed at implementation of novel and integrated laboratory testing approaches as a strategy against the spread of SARS-COV-2 in the Republic of Congo.

Explore More

A multidisciplinary consortium of African and European researchers responded to the urgent call from the European Union by developing a research project on the current Monkeypox outbreak in central Africa.

The spread of Mpox virus (MPXV) in Sub-Saharan Africa, specifically Democratic Republic of Congo (DRC) and Republic of Congo (RoC) presents an urgent public health concern with global implications. MPXV cases

With 1 million new cases and 200,000 children dead each year, Tuberculosis (TB) is now the leading cause of death from infectious diseases for children of all ages globally (UNICEF).

Ebola vaccine candidates are currently being evaluated in phase I–III clinical trials conducted in Africa, the EU and the US. Although preclinical development of candidate vaccines utilise different platforms, including